Delcath Systems Announces Postponement of Reverse Stock Split
22 oct. 2019 07h27 HE
|
Delcath Systems, Inc.
NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Systems Announces Ratio for Reverse Stock Split
18 oct. 2019 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Systems to Present at the MicroCap Rodeo Investor Conference
08 oct. 2019 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will present at the MicroCap Rodeo. The conference will be held October...
Delcath Systems to Participate in Upcoming Investor Conferences
23 sept. 2019 11h30 HE
|
Delcath Systems, Inc.
NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will participate at the following upcoming investor conferences in New...
Delcath Systems Announces Presentation at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright
28 août 2019 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will present at the Rodman & Renshaw 21st Annual Global Investment...
Delcath Systems Closes $9.5 Million Private Placement
20 août 2019 08h00 HE
|
Delcath Systems, Inc.
Bringing total financial amount raised since July 2019 to $29.5M Cash runway past top-line results in 1H2020 with NDA submission anticipated by end of 2020 Recapitalization provides possible...
Delcath Systems Announces $9.5 Million Private Placement
15 août 2019 18h02 HE
|
Delcath Systems, Inc.
NEW YORK, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH)) today announced that it has entered into a definitive agreement for...
Delcath Enhances Board of Directors With Appointment of Commercial Leader, John R. Sylvester
29 juil. 2019 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTC Pink: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces...
Results of Single Center Study on Delcath’s PHP Therapy Published in Cancer Imaging
22 juil. 2019 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCPK: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces...
Delcath Systems Closes $20 Million Private Placement
17 juil. 2019 16h05 HE
|
Delcath Systems, Inc.
NEW YORK, July 17, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCPK: DCTH) has closed on its previously announced private placement with gross...